醫師簡介

沈正煌 醫療長

外科系醫療長 泌尿外科主治醫師

學歷

國立中正大學-生物醫學科學系<分子生物研究所>博士【2007-2011】

中國醫藥學院-中醫學系【1977-1984】

經歷

國立中正大學生物醫學科學系兼任教授【現任】

台灣泌尿科醫學會結石委員會顧問現任【2018~2020】

台灣泌尿科醫學會訓練醫院評鑑委員現任【2018-2020】

台灣泌尿科醫學會雜誌委員會Section Edition現任【2018-2020】

台灣疝氣醫學會理事【現任】

台灣泌尿科醫學會口試委員【現任】

台灣泌尿科醫學會結石委員會主任委員【2016-2018】

嘉義基督教醫院醫學研究部主任【2007-2018年01月】

嘉義基督教醫院泌尿科主任【1995-1997】

嘉義基督教醫院外科部主任【1997~2006】

美國康乃爾大學【1995-1996 】

國泰醫學中心【1986-1995】



專 長:輸尿管&膀胱腫瘤
    泌尿系統雷射截石手術
    泌尿道結石
    K他命
    腎臟移植 

  • Gene therapy for castration-resistant prostate cancer cells using JC2 polyomavirus-like particles packaged with a PSA promoter driven-suicide3 gene Mien-Chun Lin, Meilin Wang, Ming-Chieh Chou, Chun-Nun Chao, Chiung-Yao Fang, Pei-Lain Chen, Deching Chang and Cheng-Huang Shen, Cancer Gene Therapy 2019 Jan 29 .s41417-019-0083-0
  • c-Myc Acts as a Competing Endogenous RNA to Sponge miR-34a, in the Upregulation of CD44, in Urothelial Carcinoma Pie-Che Chen, Chih-Chia Yu, Wen-Yu Huan, Wan-Hong Huang, Yu-Ming Chuang, Ru-Inn Lin , Jora M. J. Lin , Hon-Yi Lin , Yeong-Chin Jou , Cheng-Huang Shen and Michael W. Y. Chan, Published: 28 September 2019 Cancers 2019, 11, 1457
  • KHC-4 inhibits β-catenin expression in prostate cancer cells .Huang CY, Velmurugan BK, Chen MC, Day CH, Chien WS, Padma VV, Wu HC, Lin TH, Hsu HH, Shen. Biotech Histochem.2019 Mar 1:1-7
  • Ketamine-induced bladder dysfunction is associated with extracellular matrix accumulation and impairment of calcium signaling in a mouse model CHENG-HUANG SHEN, SHOU-TSUNG WANG, SHOU-CHIEH WANG, SHU-MEI LIN, LEI-CHEN LIN, YUAN-CHANG DAI and YI-WEN LIU Molecular Medicine Reports.January 29,2019.19: 2716-2728 2019
  • Reversine induces autophagic cell death through the AMP-activated protein kinase pathway in urothelial carcinoma cells. Fang CY, Chen JS, Chang SK,Shen CH. Anticancer Drugs. 2018 Jan;29(1):29-39.
  • Clinical and demographic characteristics among patients with urothelial carcinomas of the upper urinary tract and bladder in Taiwan. Shen CH, Chiou HY, Tung MC, Wu CC, Kao WT, Wang YH, Juang GD. J Chin Med Assoc. 2017 Sep;80(9):563-568.
  • Clinical and demographic characteristics among patients with urothelial carcinomas of the upper urinary tract and bladder in Taiwan. Shen CH, Chiou HY, Tung MC, Wu CC, Kao WT, Wang YH, Juang GD. J Chin Med Assoc. 2017 Sep;80(9):563-568.
  • Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan. Shen CH, Zheng CM, Kiu KT, Chen HA, Wu CC, Lu KC, Hsu YH, Lin YF, Wang YH. Medicine (Baltimore). 2016 Jun;95(25):e3933.
  • Association between tumor necrosis factor α-308 G/A polymorphism and bladder cancer risk: a meta-analysis. Cheng-Huang Shen, Wei-Tang Kao, Min-Che Tung, Kuan-Chun Hsueh, Chia-Chang Wu, Yuan-Hung Wang Int J Clin Exp Med 2016;9(7):14205-14211.
  • Association between tumor necrosis factor α-308 G/A polymorphism and bladder cancer risk: a meta-analysis. Cheng-Huang Shen, Wei-Tang Kao, Min-Che Tung, Kuan-Chun Hsueh, Chia-Chang Wu, Yuan-Hung Wang Int J Clin Exp Med 2016;9(7):14205-14211.
  • Chronic Kidney Disease is Associated With Upper Tract Urothelial Carcinoma: A Nationwide Population-Based Cohort Study in Taiwan. Chen JS, Lu CL, Huang LC, Shen CH, Chen SC .Medicine (Baltimore). 2016 Apr;95(14):e3255
  • The high incidence of JC virus infection in urothelial carcinoma tissue in Taiwan. Shen CH, Wu JD, Hsu CD, Jou YC, Lin CT, Wang M, Wu SF, Chan MW, Chiang MK, Fang CY, Chang D.J Med Virol. 2011 Dec;83(12):2191-9.
  • High Dickkopf-1 expression is associated with poor prognosis in patients with advanced urothelial carcinoma. Shen CH, Hsieh HY, Wang YH, Chen SY, Tung CL, Wu JD, Lin CT, Chan MW, Hsu CD, Chang D. Exp Ther Med. 2010 Sep;1(5):893-898. Epub 2010 Jul 21
  • Mitotic arrest induced in human DU145 prostate cancer cells in response to KHC-4 treatment. Shen CH, Lin TH, Hsieh YL, Shen CY, Kuo SC, Wu HC, Chien WS, Hsieh DJ, Wen SY, Ting WJ, Yao CH, Huang CY. Environmental Toxicology. 2015 Aug 25.
  • Biological effect of ketamine in urothelial cell lines and global gene expression analysis in the bladders of ketamine injected mice. Shen CH, Wang ST, Lee YR, Liu SY, Li YZ, Wu JD, Chen YJ, Liu YW. Mol Med Rep. 2015 Feb;11(2):887-95.
  • Evaluation of Urinary Bladder Fibrogenesis in Mouse Model of Long-term Ketamine Injection Shen CH, Wang SC, Wang ST, Lin SM, Wu JD, Lin CT, Liu YW. Mol Med Rep. 2016 Jul 7.
  • Inhibition of human bladder cancer growth by a suicide gene delivered by JC polyomavirus virus-like particles in a mouse model. Fang CY, Tsai YD, Lin MC, Wang M, Chen PL, Chao CN, Huang YL, Chang D, Shen CH. J Urol. 2015 Jun;193(6):2100-6.
  • Clinical significance of survivin expression in patients with urothelial carcinoma. Chen HA, Su CM, Hsieh HY, Tung CL, Hsu CD, Wang YH, Shen CH. Dis Markers. 2014 Feb:574985.
  • Huge bilateral renal angiomyolipoma. Shen CH1, Tung CL, Yan YH, Cheng MC. BMJ Case Rep. 2013 Jan 25;2013.
  • The correlation between TWIST, E-cadherin, and beta-catenin in human bladder cancer. Shen CH1, Wu JD, Jou YC, Cheng MC, Lin CT, Chen PC, Tseng YS, Shi CS, Chen SY, Chang DC, Lee YR .Journal of BUON 16: 733-737, 2011
  • Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model. Shen CH1, Shee JJ, Wu JY, Lin YW, Wu JD, Liu YW.Br J Pharmacol. 2010 Aug;160(8):2008-27.
  • Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population. Wang YH1, Chiou HY, Lin CT, Hsieh HY, Wu CC, Hsu CD, Shen CH. Urology. 2009 Mar;73(3):670-4.
  • Innovative metal dilators for percutaneous nephrostomy tract: report on 546 cases. Shen CH1, Cheng MC, Lin CT, Jou YC, Chen PC .Urology. 2007 Sep;70(3):418-21; discussion 421-2.
  • Inducible nitric oxide synthase promoter polymorphism, cigarette smoking, and urothelial carcinoma risk. Shen CH1, Wang YH, Wang WC, Jou YC, Hsu HS, Hsieh HY, Chiou HY. Urology. 2007 May;69(5):1001-6
  • Nephrostomy tube-free percutaneous nephrolithotomy for patients with large stones and staghorn stones. Jou YC1, Cheng MC, Lin CT, Chen PC, Shen JH. Urology. 2006 Jan;67(1):30-4
  • A simple means of making the differential diagnosis of ureterouterine and vesicouterine fistula. Sheen JH1, Lin CT, Jou YC, Cheng MT.J Urol. 1998 Oct;160(4):1420

泌尿外科

  • 沈正煌
    醫療長
  • 周詠欽
    外科部部主任
  • 陳丕哲
    主治醫師
  • 鄭明進
    碎石中心主任
  • 林昌德
    主治醫師
  • 賴韋宏
    主治醫師
  • 陳柏仲
    主治醫師
  • 張恩承
    主治醫師
Back to top